Get the Stockscreener App
80.51
0.31%
-0.25
Dexcom Inc stock is traded at $80.51, with a volume of 2.67M.
It is down -0.31% in the last 24 hours and up +6.69% over the past month.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.
See More
Previous Close:
$80.76
Open:
$80.875
24h Volume:
2.67M
Relative Volume:
0.73
Market Cap:
$31.57B
Revenue:
$4.30B
Net Income/Loss:
$571.50M
P/E Ratio:
55.91
EPS:
1.44
Net Cash Flow:
$570.80M
1W Performance:
+6.86%
1M Performance:
+6.69%
6M Performance:
-1.77%
1Y Performance:
+16.60%
1-Day Range:
$79.48
$81.60
1-Week Range:
$73.47
$81.64
52-Week Range:
$57.52
$93.25
Dexcom Inc Stock (DXCM) Company Profile
Name
Dexcom Inc
Sector
Industry
Phone
(858) 200-0200
Address
6340 SEQUENCE DRIVE, SAN DIEGO, CA
Compare DXCM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DXCM
Dexcom Inc
|
80.51 | 31.67B | 4.30B | 571.50M | 570.80M | 1.44 |
|
ABT
Abbott Laboratories
|
132.94 | 231.15B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
107.22 | 158.98B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
392.31 | 150.76B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.90 | 119.10B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
80.94 | 47.53B | 5.69B | 1.41B | 577.90M | 6.95 |
Dexcom Inc Stock (DXCM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-21-25 | Initiated | Argus | Buy |
| Jun-16-25 | Initiated | Truist | Buy |
| May-30-25 | Initiated | Goldman | Buy |
| Apr-10-25 | Initiated | Mizuho | Outperform |
| Feb-03-25 | Upgrade | Redburn Atlantic | Neutral → Buy |
| Jan-16-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jul-26-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-26-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-30-24 | Initiated | Redburn Atlantic | Neutral |
| Mar-12-24 | Initiated | RBC Capital Mkts | Outperform |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| Apr-17-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Mar-29-23 | Initiated | UBS | Buy |
| Jan-26-23 | Initiated | Wolfe Research | Outperform |
| Oct-18-22 | Initiated | Barclays | Equal Weight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Jul-15-22 | Initiated | Bernstein | Outperform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Feb-03-22 | Upgrade | BTIG Research | Neutral → Buy |
| Jan-19-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-07-22 | Upgrade | Guggenheim | Neutral → Buy |
| Oct-18-21 | Downgrade | Guggenheim | Buy → Neutral |
| Jul-21-21 | Resumed | Cowen | Outperform |
| May-28-21 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-15-21 | Initiated | Atlantic Equities | Overweight |
| Jan-06-21 | Upgrade | UBS | Neutral → Buy |
| Oct-02-20 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| May-27-20 | Reiterated | Piper Sandler | Overweight |
| May-14-20 | Initiated | Wells Fargo | Equal Weight |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Nov-07-19 | Reiterated | Canaccord Genuity | Buy |
| Nov-07-19 | Upgrade | Guggenheim | Neutral → Buy |
| Oct-23-19 | Initiated | Stifel | Buy |
| Nov-28-18 | Initiated | UBS | Neutral |
| Oct-19-18 | Upgrade | Goldman | Sell → Neutral |
| Sep-12-18 | Upgrade | Northland Capital | Under Perform → Market Perform |
| Aug-02-18 | Reiterated | Canaccord Genuity | Buy |
| Jul-02-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jun-08-18 | Upgrade | JP Morgan | Neutral → Overweight |
| May-11-18 | Initiated | BofA/Merrill | Buy |
| May-03-18 | Reiterated | Canaccord Genuity | Buy |
| Apr-04-18 | Initiated | Goldman | Sell |
| Apr-04-18 | Initiated | Guggenheim | Neutral |
| Mar-23-18 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jan-04-18 | Downgrade | Northland Capital | Market Perform → Under Perform |
| Sep-28-17 | Reiterated | Wedbush | Outperform |
View All
Dexcom Inc Stock (DXCM) Latest News
What is DexCom Inc. s P E ratio telling usLong Setup & Free Safe Capital Growth Stock Tips - 강소기업뉴스
Should I average down on DexCom Inc. stock2025 Biggest Moves & Fast Moving Stock Trade Plans - خودرو بانک
DexCom Faces Evaluation Adjustment Amid Strong Financial Performance and Quality Concerns - Markets Mojo
What the charts say about DexCom Inc. todayJuly 2025 Analyst Calls & Low Risk Investment Opportunities - Newser
Can trapped investors hope for a rebound in DexCom Inc.Day Trade & Technical Pattern Based Signals - Newser
What recovery options are there for DexCom Inc.Market Risk Analysis & Accurate Entry and Exit Point Alerts - Newser
What momentum shifts mean for DexCom Inc.Portfolio Update Report & Free Expert Verified Stock Movement Alerts - Newser
Using RSI to spot recovery in DexCom Inc.Earnings Recap Report & Smart Money Movement Tracker - Newser
Analyzing DexCom Inc. with risk reward ratio chartsBull Run & Safe Capital Growth Stock Tips - Newser
Ranking DexCom Inc. among high performing stocks via toolsWeekly Gains Summary & Real-Time Volume Spike Alerts - Newser
Using data filters to optimize entry into DexCom Inc.July 2025 Drop Watch & Reliable Price Breakout Alerts - Newser
How to monitor DexCom Inc. with trend dashboardsOptions Play & AI Powered Market Entry Strategies - Newser
Dexcom shares fall 1.19% after-hours as insider sells $357,796 worth of shares. - AInvest
Assessing the Impact of Insider Share Sales on Investor Confidence in Dexcom (DXCM) - AInvest
Dealogic: DEXCOM INC EVP Jereme Sells 4824 Shares at $74.17/Share on 2025-09-02 - AInvest
Dexcom to lay off about 350 people - MedTech Dive
Why DexCom (DXCM) Stock Is Up Today - TradingView
Will DexCom Inc. outperform tech stocks2025 Volatility Report & Capital Efficiency Focused Ideas - خودرو بانک
Dexcom, Inc. shares rise 3.35% intraday after positive presentation at Wells Fargo 20th. - AInvest
Understanding DexCom Inc.’s price movementGap Down & Risk Adjusted Buy and Sell Alerts - Newser
Market reaction to DexCom Inc.’s recent newsPortfolio Risk Report & AI Driven Price Forecasts - Newser
Applying Wyckoff theory to DexCom Inc. stockWeekly Stock Analysis & Verified Chart Pattern Signals - Newser
Signal strength of DexCom Inc. stock in tech scannersJuly 2025 Spike Watch & Long-Term Investment Growth Plans - Newser
Is DexCom Inc. backed by strong institutional buyingDollar Strength & Real-Time Sentiment Analysis - خودرو بانک
Calif. biotech company Dexcom lays off hundreds amid shift to Arizona - SFGATE
DexCom Inc. stock outperforms competitors on strong trading day - MarketWatch
Transcript : DexCom, Inc. Presents at Wells Fargo 20th Annual Healthcare Conference 2025, Sep-03-2025 02 - MarketScreener
Dexcom shares jump, up 4.9%, a session high - AInvest
What data driven models say about DexCom Inc.’s future2025 Price Momentum & Reliable Entry Point Trade Alerts - Newser
Published on: 2025-09-03 08:54:41 - Newser
How to recover losses in DexCom Inc. stockWeekly Market Report & Comprehensive Market Scan Reports - Newser
Will DexCom's (DXCM) Latest Investor Update Hint at a Shifting Innovation Strategy? - simplywall.st
Analyzing drawdowns of DexCom Inc. with statistical toolsTrade Risk Assessment & High Conviction Buy Zone Alerts - Newser
Custom watchlist performance reports with DexCom Inc.July 2025 Market Mood & Scalable Portfolio Growth Ideas - Newser
Tools to assess DexCom Inc.’s risk profileWeekly Profit Summary & Safe Entry Trade Reports - Newser
What candlestick patterns are forming on DexCom Inc.2025 Institutional Moves & Weekly Breakout Watchlists - Newser
Exit strategy if you’re trapped in DexCom Inc.July 2025 Analyst Calls & Daily Stock Trend Watchlist - Newser
Published on: 2025-09-03 23:05:34 - Newser
Custom watchlist performance reports with DexCom IncMarket Performance Report & Fast Moving Stock Watchlists - Newser
Stock Analysis | Dexcom OutlookWeak Technicals and Mixed Analyst Sentiment - AInvest
Should you hold or exit DexCom Inc. nowTrade Analysis Summary & Free Fast Gain Swing Trade Alerts - Newser
Dexcom Trails Medtronic in Diabetes Tech Race as $330M Volume Marks 343rd Market Rank - AInvest
What to do if you’re stuck in DexCom Inc.Trade Risk Summary & Free High Return Stock Watch Alerts - Newser
DexCom Loses EU Patent For Glucose Sensor Design - Law360
Dexcom Inc Stock (DXCM) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.17%
0.02%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):